These Bluetooth headphones promise to be the first in the world to feature a valve-based preamp stage, a DAC and dual-mono ...

Hey there, Let’s be honest about traditional earbuds for a second. Yes, shoving a silicone plug deep into your ear canal gives you great noise cancellation. It also gives you a weird sense of ...

To support its growth, EPR has no balance on its $1 billion revolving line of credit, an investment-grade balance sheet, and ...

Its high price keeps it squarely in luxury territory, but the SteelSeries Arctis Nova Elite is one of the best-sounding and best-feeling wireless gaming headsets I've used in my many years of testing.

The S&P 500 Rule of 20 score hits 32.2 as AI productivity shifts baseline P/E ratios and inflation, signaling higher returns. Read more about tactical sector allocations here.

Add Yahoo as a preferred source to see more of our stories on Google. Adjust your ears and prepare yourself. The THX logo (and its sound systems) might be returning to movie theaters. In a truly ...

Adjust your ears and prepare yourself. The THX logo (and its sound systems) might be returning to movie theaters. In a truly thrilling update posted to social media on Thursday, THX shared a simple ...

A rescue bid to save one of Australia’s most popular sports outlets, The Roar, has fallen over amid a dispute over its ownership and responsibility for paying staff, which has resulted in the website ...

Brisbane Roar and Sydney FC are set to clash for the first time since their pre-season trial was abandoned early due to aggressive play that shocked the referee. Due to another example of bizarre ...

Liam Gaughan is a film and TV writer at Collider. He has been writing film reviews and news coverage for ten years. Between relentlessly adding new titles to his watchlist and attending as many ...

Biocodex secures rights to Batten-1 and TX01 in agreement worth up to €173 million THX Pharma and Biocodex have entered a strategic licensing agreement covering three rare diseases, with Biocodex ...

Biocodex has acquired two licenses from THX Pharma to develop and commercialize Batten-1 worldwide and TX01 in the United States and Canada. The total deal value is up to €173 million, including a €12 ...